Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F71UL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,860
Award facts
- Contract value 100% obligated
- $14,860.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,860.16 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections with a firm fixed price structure. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, and represents a non-competitive, non-set-aside procurement. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as the company's primary pharmaceutical supply mechanism for military healthcare systems globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and a critical vendor for federal medical procurement, particularly within the Department of Defense supply chain. The company's extensive contract portfolio with DLA demonstrates its capability to deliver a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare systems. This specific delivery order for Zepbound reflects the company's role in supplying diabetes and weight management medications to federal healthcare beneficiaries within the broader DLA pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26F71UL?
SPE2DR26F71UL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26F71UL worth?
The government has obligated $14,860 on SPE2DR26F71UL.
Is contract SPE2DR26F71UL an order under another contract?
Yes. SPE2DR26F71UL is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F71UL competed?
The extent of competition for SPE2DR26F71UL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award